Nureca Ltd (NURECA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003462,
    "name": "Nureca",
    "stock_name": "Nureca",
    "full_name": "Nureca Ltd",
    "name_url": "stocks-analysis/nureca",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "238.55",
    "chg": -0.15,
    "chgp": "-0.06%",
    "dir": -1,
    "prev_price": "238.70",
    "mcapval": "227.62 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543264,
    "symbol": "NURECA",
    "ind_name": "Healthcare Services",
    "ind_code": 26,
    "indexname": "India SENSEX",
    "isin": "INE0DSF01015",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "6.97 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/nureca-1003462-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Nureca Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-sell-4000674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NurecaLtd_mojoScore_4000674.png",
        "date": "2026-05-20 10:10:56",
        "description": "Nureca Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Nureca Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-sell-by-marketsmojo-3982704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NurecaLtd_mojoScore_3982704.png",
        "date": "2026-05-09 10:10:36",
        "description": "Nureca Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Nureca Ltd Gains 8.82%: 3 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-gains-882-3-key-factors-driving-the-weeks-volatility-3942587",
        "imagepath": "",
        "date": "2026-04-11 12:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Valuation metrics signal expensive territory amid sector challenges</p>\n                    <p><strong>7 Apr:</strong> Formation of Death Cross indicates potential bearish trend</p>\n                    <p><strong>8 Apr:</strong> Mojo Grade downgraded to Strong Sell reflecting technical and fundamental weakness</p>\n                    <p><strong>10 Apr:</strong> Week closes at Rs.260.95, up 8.82% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.239.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label..."
      },
      {
        "title": "Nureca Ltd Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-forms-death-cross-signalling-potential-bearish-trend-3936130",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NurecaLtd_dealthcross_3936130.png",
        "date": "2026-04-07 18:00:41",
        "description": "Nureca Ltd, a micro-cap player in the Healthcare Services sector, has recently formed a Death Cross, a technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock’s medium to long-term outlook."
      },
      {
        "title": "Nureca Ltd Valuation Shifts Signal Price Attractiveness Concerns Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-valuation-shifts-signal-price-attractiveness-concerns-amid-sector-challenges-3933721",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NurecaLtd_valuationdot_3933721.png",
        "date": "2026-04-06 08:01:36",
        "description": "Nureca Ltd, a micro-cap player in the healthcare services sector, has seen a notable shift in its valuation parameters, moving from fair to expensive territory. Despite a recent day gain of 5.87%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now exceed historical and peer averages, raising questions about its price attractiveness amid subdued returns and deteriorating profitability metrics."
      },
      {
        "title": "Nureca Ltd Locks at Upper Circuit With 10% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-surges-to-upper-circuit-on-robust-buying-pressure-3928915",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NurecaLtd_stocks_hitting_upper_circuit_3928915.png",
        "date": "2026-04-01 11:00:24",
        "description": "At Rs 227.42, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Nureca Ltd locked at its upper circuit of 10% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Nureca Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-sell-by-marketsmojo-3909739",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NurecaLtd_mojoScore_3909739.png",
        "date": "2026-03-24 10:10:29",
        "description": "Nureca Ltd is rated Sell by MarketsMOJO, with this rating last updated on 09 Mar 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 15,
    "sid": "1003462",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/nureca-1003462"
  },
  "announcements": [
    {
      "caption": "Nureca Limited Has Informed The Exchange Regarding Disclosure Under Regulation 7(2) Of SEBI (PIT) Regulations 2015",
      "datetime": "10-Jun-2026",
      "details": "Nureca Limited has informed the exchange regarding disclosure under Regulation 7(2) of SEBI(PIT) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Nureca Limited Has Informed The Exchange Regarding No Change In The Aggregate Shareholding Of The Promoter And Promoter Group Of The Company Pursuant To Inter Se Transfer Of Shares.",
      "datetime": "10-Jun-2026",
      "details": "Nureca Limited has informed the Exchange regarding no change in the aggregate shareholding of the Promoter and Promoter Group of the Company pursuant to inter se transfer of shares.",
      "source": "BSE"
    },
    {
      "caption": "Nureca Limited Has Informed The Exchange Regarding Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations)",
      "datetime": "09-Jun-2026",
      "details": "Nureca Limited has informed the exchange regarding Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 (PIT Regulations)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Nureca Ltd has declared <strong>30%</strong> dividend, ex-date: 24 Feb 22",
          "dt": "2022-02-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Nureca Ltd is Rated Sell

2026-05-20 10:10:56

Nureca Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Nureca Ltd is Rated Sell by MarketsMOJO

2026-05-09 10:10:36

Nureca Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Nureca Ltd Gains 8.82%: 3 Key Factors Driving the Week’s Volatility

2026-04-11 12:00:05

Key Events This Week 6 Apr: Valuation metrics signal expensive territory amid sector challenges 7 Apr: Formation of Death Cross indicates potential bearish trend 8 Apr: Mojo Grade downgraded to Strong Sell reflecting technical and fundamental weakness 10 Apr: Week closes at Rs.260.95, up 8.82% for the week Week OpenRs.239.80 <div class="stat-label...

Nureca Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-04-07 18:00:41

Nureca Ltd, a micro-cap player in the Healthcare Services sector, has recently formed a Death Cross, a technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock’s medium to long-term outlook.

Nureca Ltd Valuation Shifts Signal Price Attractiveness Concerns Amid Sector Challenges

2026-04-06 08:01:36

Nureca Ltd, a micro-cap player in the healthcare services sector, has seen a notable shift in its valuation parameters, moving from fair to expensive territory. Despite a recent day gain of 5.87%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now exceed historical and peer averages, raising questions about its price attractiveness amid subdued returns and deteriorating profitability metrics.

Nureca Ltd Locks at Upper Circuit With 10% Gain — Buyers Queue, Sellers Absent

2026-04-01 11:00:24

At Rs 227.42, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Nureca Ltd locked at its upper circuit of 10% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Nureca Ltd is Rated Sell by MarketsMOJO

2026-03-24 10:10:29

Nureca Ltd is rated Sell by MarketsMOJO, with this rating last updated on 09 Mar 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

View All News